PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
Kantar today unveiled a dynamic new health report that provides a clear line of sight to the most important factors shaping the highly-complex global healthcare market. The report, "Healthcare 2020: The 10 Key Influencers of Global Health and Wellness," enables key industry stakeholders to achieve a better understanding of the magnitude of diseases and the many aspects of health-related outcomes – both within and across country lines. - October 08, 2019 - Kantar
SMi Reports: Four interactive sessions will take place at the inaugural Respiratory Drug Delivery conference to be held on the 6th December in London. - October 06, 2019 - SMi Group
RE Pharmacy announces a new infusion center, in partnership with neurologist David Saperstein, MD and the the Center of Complex Neurology in Phoenix, AZ. - October 03, 2019 - RE Pharmacy
SMi Reports: Registration is open for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. - October 03, 2019 - SMi Group
SMi Reports: Key discussions surrounding the use of AI in Pharmaceuticals will take place at the inaugural Disruptive Technologies in Pharma conference in London on January 20 and 21. - September 30, 2019 - SMi Group
Omni Health, Inc., (OTC: OMHE) Andrey Soloviev announces his resignation from the position of CEO of Omni Health, Inc. effective 08/20/2019.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term... - September 27, 2019 - Omni Health
SMi Reports: New developments for respiratory devices are making headlines ahead of the Respiratory Drug Delivery conference this December. - September 26, 2019 - SMi Group
Ophthalmics, Inc., a leading wholesale supplier of eye care supplies for ophthalmic and optometric practices, is now a direct distributor for Akorn, Inc. Customers are encouraged to visit Ophthalmics, Inc.’s website at www.shophthalmics.com to find Akorn’s line of industry leading pharmaceuticals.
Akorn,... - September 25, 2019 - Ophthalmics, Inc.
Dedicated to “Safe and effective medicines for all” - September 25, 2019 - Temos International GmbH
SMi Reports: Invitation letter released from the chairs of the Pre-Filled Syringes and Injectable Drugs conference taking place in January 2020. - September 25, 2019 - SMi Group
In 2017, the Indian Government introduced a National Health Policy (Ayushman Bharat or Healthy India) that aims to offer universal health coverage and provide the foundation for equitable healthcare. In this paper, SKP examines the potential of the NHPS and attempts to study the impact it creates on healthcare accessibility along with opportunities created for various stakeholders in the industry. - September 22, 2019 - SKP Group
SMi Reports: Spotlight session presentations have been released for the 5th annual Lyophilization USA conference held in Boston, USA on October 23 and 24. - September 22, 2019 - SMi Group
Oncoheroes Biosciences Inc (“Oncoheroes”) and Boehringer Ingelheim International GmbH (“Boehringer Ingelheim”) have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered and developed by Boehringer... - September 19, 2019 - Oncoheroes Biosciences Inc.
SMi Reports: Exclusive interview with industry expert from Novartis, 3 weeks ahead of the inaugural Wearable Injectors and Connected Devices conference 2019. - September 19, 2019 - SMi Group
SMi Reports: SMi's 9th annual Biobanking Conference will take place at the Copthorne Tara Hotel, London, on the 25th – 26th September 2019. - September 18, 2019 - SMi Group
SMi Reports: London awarded top spot for Trip Advisor Travellers’ Choice Awards 2019 where SMi’s Inaugural Pharmaceutical Manufacturing & Cleanroom Technology conference will take place next month. - September 14, 2019 - SMi Group
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of expression... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Chinese Pharma Growth Stabilizes amid Deepening Healthcare and Drug Regulatory Reform. - September 09, 2019 - WiCON International Group LLC
HCA Healthcare/HealthONE’s The Medical Center of Aurora (TMCA) announced that Hallie Woods has been promoted to Chief Operating Officer for TMCA and Spalding Rehabilitation Hospital. Woods previously served as Chief Administrative Officer of Centennial Medical Center (CMC), a campus of The Medical... - September 06, 2019 - The Medical Center of Aurora
The city of San Diego has all the components to become a global R&D hub, and Bench International is announcing its footprint and commitment to make a direct impact by building the hub’s position on the global life science stage.
Effective Sept. 1, Bench International has become embedded in... - September 05, 2019 - Bench International
Pleased to announce a new distribution partnership between Global Regenerative Group, a company which has developed extensive experience in the most advanced medical device industries, and Kanfit3D. - September 05, 2019 - Global Regenerative Group
Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to the... - September 05, 2019 - Cayman Chemical Company
SCPC Will Seek Cap “As Low as Possible” in Final Bill, Offer Two Policy Refinements - September 03, 2019 - Senior Care Pharmacy Coalition
SMi Reports: Mike Page, Executive Director Global Regulatory Affairs Portfolio Products at Alexion Pharmaceuticals invites heads of medical affairs and all who are interested to SMi’s 9th Annual Conference on Orphan Drugs & Rare Diseases. - September 01, 2019 - SMi Group
Focus on HPAPI USA Conference technology content - August 31, 2019 - SMi Group
CrystalGenomics, Inc. (KOSDAQ: 083790) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CG-745, a clinical stage histone deacetylase (HDAC) inhibitor being developed for several hematologic malignancies and solid tumors, for the treatment of patients... - August 30, 2019 - CrystalGenomics, Inc.
SMi Reports: SMi presents workshops for the upcoming Biobanking conference this September with industry experts Laurent Dolle, Managing Director, BWB and Mary-beth Joshi, Director, Biobank. - August 29, 2019 - SMi Group
HealthONE, Denver’s largest health system, and CarePoint Health of Greenwood Village, CO, one of the nation’s largest privately held physician practice groups, today announced a dramatic decline in the number of opioids prescribed at 13 Denver-area HealthONE Emergency Departments.
CarePoint... - August 28, 2019 - HealthONE
Admini-Care.com is the new website for AdminiCare Medical Supplies Inventory Platform from InBeam Technologies. Previously, Admini-Care was located in the parent InBeam website.
With the launch of the integrated platform, AdminiCare now has its own site.
Complete details on the integrated platform... - August 28, 2019 - inBeam Technologies
SMi Reports: Regulation and policy to be a focus topic at the Wearable Injectors and Connected Devices conference this October. - August 22, 2019 - SMi Group
New York Cancer & Blood Specialists (NYCBS) proudly welcomes Tina Toulon, an accomplished expert in sales and relationship building, as a physician liaison to its Long Island team. Ms. Toulon will be responsible for NYCBS’ Suffolk and Nassau Counties.
Toulon holds skills in collaborative selling... - August 20, 2019 - New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) proudly welcomes Neil Foley, a talented and experienced pharmaceutical representative to its city team as a physician liaison. Foley will bring over 21 years of experience of pharmaceutical expertise. He will be working out of NYCBS’ Bronx, Manhattan,... - August 20, 2019 - New York Cancer & Blood Specialists
SMi Reports: Registration is open for SMi Group’s 12th annual conference and exhibition taking place in January 2020 in London. - August 17, 2019 - SMi Group
Access Regulatory Partners (ARP) announced today its new service, DMFGateway™ to register Drug Master File in China for API Manufacturers worldwide. The new offering is part of ARP’s initiatives to help pharmaceutical, chemical and other industries to expand or strengthen their base in China.
“Since... - August 16, 2019 - Access Regulatory Partners, Inc.
SMi Reports: Learn from key opinion leaders at the Respiratory Drug Delivery conference this December. - August 14, 2019 - SMi Group
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
Latest accolade follows a year of 30% revenue growth and thought leadership. - August 09, 2019 - Arteric
Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system.
It is estimated that there are around 150 million people worldwide... - August 05, 2019 - Quantum Genomics
Global Regenerative Group, developer and global distributor of new and innovative products in the field of Regenerative Medicine, today announces its partnership with Prosupplier GmbH, a pharmaceutical wholesaler with an experienced and specialist team, whose products include CureOs® Synthetic BONE GRAFT. - August 02, 2019 - Global Regenerative Group
SMi Reports: SMi has released an exclusive interview with industry expert Dr Sigbjorn Gregusson, Managing Director, BioBank AS ahead of the upcoming Biobanking conference this September. - July 31, 2019 - SMi Group
Site neutral policies in the Prescription Drug Pricing Reduction Act (PDPRA) of 2019 approved by the Senate Finance Committee will lower out-of-pocket costs for seniors. - July 26, 2019 - Alliance For Site Neutral Payment Reform
SMi Reports: The 2019 Respiratory Drug Delivery conference to host three interactive sessions this December. - July 20, 2019 - SMi Group
SMi Group reports: This year’s Biosimilars event will focus on forecasting future regulatory, commercial and legal challenges to advance biosimilars uptake. - July 20, 2019 - SMi Group
The Medical Imaging & Technology Alliance (MITA), along with the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) and the Society of Nuclear Medicine & Molecular Imaging (SNMMI), today applauded Representative Scott Peters (CA-52), George Holding (NC-2) and Bobby Rush (IL-1) for... - July 17, 2019 - Medical Imaging and Technology Alliance
SMi Reports: SMi is pleased to share the two-day agenda, the expert speaker line-up and the importance of attending the inaugural Pharmaceutical Cleanroom Technology Conference. - July 15, 2019 - SMi Group
SMi Report: Respiratory Drug Delivery conference will be taking place on 5th – 6th December 2019; the brochure is now available to download. - July 12, 2019 - SMi Group
No demographic group is immune to the nation’s current opioid epidemic. Hundreds of thousands of young Americans misuse opioids annually as the percentage of overdose deaths continue to rise. RehabNear.me was introduced as an online resource for the individuals suffering the effects of substance... - July 11, 2019 - RehabNear.me
Kenworthy Capital is a recently initiated impact investment fund that has vowed to donate a percentage of income to fund research efforts on auto-immune disease like celiac disease. - July 10, 2019 - Kenworthy Capital
Mitchell de Long, Vice President of Chemistry from Aerie Pharmaceuticals will discuss the launch of Rocklatan in the USA. - July 03, 2019 - SMi Group